Clinical trial specialist WIRB-Copernicus Group launched a new product aimed at upping the efficiency and profitability of clinical research operators at institutions and independent research sites.
Dubbed SiteReady, the product is an end-to-end solution designed to make research more efficient and easier to manage by reducing the administrative burden of regulatory compliance, streamlining contract and budget negotiations, speeding up study start-up and builds patient enrollment in clinical trials.
“The research ecosystem is changing rapidly; protocols are increasingly complex, research teams are stretched thin, and patients are more informed than ever,” Donald Deieso, chair and CEO of WCG, said in a statement. “Biopharmaceutical companies are seeking investigators who can perform clinical studies at the highest level of efficiency and integrity.
“Conversely, leading investigative sites desire opportunities to participate in the exciting advances being developed by the industry. To succeed in this highly competitive landscape, investigators and site teams must continually position themselves for growth.”
Earlier this year WCG upped its presence in the clinical trial management solutions business with the addition of CTMS specialist Velos eResearch. That deal fell six months after WCG snapped up KMR Group and Metrics Consortium in an acquisition, bolstering is market insights and intelligence division.